Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4541185012 | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4541186013 | Epidermal growth factor receptor antagonist antineoplastic agent | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | est un(e) (attribut) | inhibiteur enzymatique | false | Inferred relationship | Some | ||
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | est un(e) (attribut) | Product containing protein kinase inhibitor (product) | true | Inferred relationship | Some | ||
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | est un(e) (attribut) | Medicinal product acting as antineoplastic agent (product) | true | Inferred relationship | Some | ||
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | a pour principe actif (attribut) | substance avec mécanisme d'action inhibiteur du récepteur du facteur de croissance épidermique (substance) | true | Inferred relationship | Some | 1 | |
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | est un(e) (attribut) | Medicinal product categorized by disposition (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing osimertinib (medicinal product) | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Necitumumab-containing product | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing gefitinib (medicinal product) | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing erlotinib (medicinal product) | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing vandetanib (medicinal product) | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing lapatinib (medicinal product) | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing trastuzumab deruxtecan (medicinal product) | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing trastuzumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| pertuzumab | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Trastuzumab emtansine-containing product | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Margetuximab-containing product | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| médicament contenant amivantamab | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing cetuximab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing protein-tyrosine kinase inhibitor (product) | est un(e) (attribut) | False | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some | |
| Product containing panitumumab (medicinal product) | est un(e) (attribut) | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR